Kenneth C Bagley
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.1MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $6.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 28, 2018 | NIH | SBIR Phase II Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine | $993K | PROFECTUS BIOSCIENCES, INC. |
| Jul 13, 2017 | NIH | SBIR Phase II Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine | $838K | PROFECTUS BIOSCIENCES, INC. |
| Jun 5, 2017 | NIH | SBIR Phase I Therapeutic Vaccine for Walnut and Pecan Allergies | $241K | PROFECTUS BIOSCIENCES, INC. |
| Jun 1, 2017 | NIH | SBIR Phase II Novel Mucosal Adjuvant for an HIV DNA Vaccine | $793K | PROFECTUS BIOSCIENCES, INC. |
| Jul 21, 2016 | NIH | SBIR Phase II Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine | $969K | PROFECTUS BIOSCIENCES, INC. |
| Jun 29, 2016 | NIH | SBIR Phase II Novel Mucosal Adjuvant for an HIV DNA Vaccine | $734K | PROFECTUS BIOSCIENCES, INC. |
| Aug 21, 2015 | NIH | SBIR Phase II Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine | $998K | PROFECTUS BIOSCIENCES, INC. |
| Apr 15, 2015 | NIH | SBIR Phase II Optimization of a DNA Subunit Regimen for an HIV Vaccine | $549K | PROFECTUS BIOSCIENCES, INC. |
Peer ranks
Federal funding#180
Awards as PI#190
Patents#273
Companies
- PROFECTUS BIOSCIENCES, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.